- This event has passed.
BioNJ’s 9th Annual BioPartnering Conference
May 8 @ 7:30 am - 5:30 pm
Event closed to media.
Innovation on the Rise:
New Partnering Paradigms & Pathways
7:30 a.m.-8:45 a.m.: Registration & Networking Breakfast
8:45 a.m.-4:30 p.m.: Program
4:30 p.m.: Closing Remarks & Reception
Developed with J.P. Morgan and Johnson & Johnson Innovation, BioNJ’s Ninth Annual Biopartnering Conference, taking place Wednesday, May 8, 2019, will bring together over 400 regional biopharmaceutical executives, investors, academic collaborators and business development professionals from the Northeast to Mid-Atlantic states for a day of networking, 1-1 partnering meetings, company presentations, exhibits and plenary sessions.
|7:30 a.m.–8:40 a.m.||Registration and Networking Breakfast|
|8:40 a.m.–9:00 a.m.||Welcome & Opening Remarks
Debbie Hart, President & CEO, BioNJ
|9:00 a.m.–9:30 a.m.||An Industry Update and Trends Overview
Michael Griffin, Managing Director, Senior Investment Specialist, J.P. Morgan
Robbie Huffines, Global Chairman, Investment Banking, J.P. Morgan
|9:30 a.m.–10:20 a.m.||Panel: Diverse New Pathways to Strategic Partnering
Chip Baird, Chief Financial Officer, bluebird bio
Matthew Roden, Ph.D., Head, Strategic Corporate Development & Global Business Development Assessment, Bristol-Myers Squibb
Debi Watson, Head, Oncology Business Development Group, Johnson & Johnson Innovation, Janssen Business Development
Moderator: John Whittaker, MBA, Executive Director, Healthcare Investment Banking, J.P. Morgan
|10:30 a.m.–12:00 p.m.||Company Presentations & Partnering Meetings|
|12:00 p.m.–12:30 p.m.||Networking/Company Presentations Q&A/Partnering Meetings/Exhibits|
|12:30 p.m.–1:20 p.m.||Networking Lunch|
|1:20 p.m.–1:50 p.m.||Fireside Chat: Paving Pathways to a “World Without Disease”
William N. Hait, M.D., Ph.D., Global Head, Johnson & Johnson External Innovation
In Conversation With: Debbie Hart, President & CEO, BioNJ
|2:00 p.m.–3:30 p.m.||Company Presentations & Partnering Meetings|
|2:00 p.m.–3:30 p.m.||Institution / Start-up Track: Investor Panel Discussion and Pitch Presentations
Sonia Gulati, Ph.D., Executive in Residence. Kairos Ventures
Edward Rosen, Founder, Glendevon Life Sciences
Donald Very, Ph.D., Chief Technical Analyst, Devices and Diagnostics, Velocity Fund Management, LLC
Michael Wiley, Vice President, New Jersey Health Foundation/Foundation Venture Capital Group, LLC
Moderator: Michal Preminger, Ph.D., MBA, Head, Johnson & Johnson Innovation, East North America
|3:30 p.m.–4:00 p.m||Networking/Company Presentations Q&A/Partnering Meetings/Exhibits|
|4:00 p.m.–4:30 p.m.||Fireside Chat: Partnering Imperatives and Navigating to Commercialization
Brian Flood, Managing Director, J.P. Morgan
Patrik Ringblom, Global Commercial Strategy Leader, Janssen
|4:30 p.m.||Closing Remarks|
Registration is $350 for BioNJ Members and $395 for Future Members. Contact Samantha Bamberger at 609-890-3185 or BioPartnering@BioNJ.org with questions.
A room block has been confirmed for the night of May 7th at the Fairfield Inn and Suites (315 Davidson Avenue, Somerset, NJ). Rate is $165 under BioPartnering.
Access your partnering schedule on the go using our free mobile app for iPhone and Android. Search for “One-on-One” in your app store.
Click Here for Driving Directions to The Palace at Somerset Park
Thank You to Our Supporting Partners
Thank You to Our Sponsors